Zero per cent on principle: Bruggefarma refuses to pay the Bruges CPAS an ‘administrative cost’ because medicines law allegedly forbids it, finishes last — and gets nowhere at the Council of State
The Bruges CPAS (public social welfare centre) asked pharmacists bidding to supply medicines and care products to three care homes for a percentage of turnover as an ‘administrative cost’, worth 70 of 100 points; Bruggefarma entered 0% because any benefit to an institution in the dispensing of medicines was allegedly prohibited, finished last with 30 points against 79.75 for Patrona Pharma Group (30%), and saw its extreme-urgency application dismissed because the prohibition does not cover the care products that were also part of the contract.
What happened?
On 1 October 2010 the social welfare council of the Bruges CPAS decided to launch a general call for tenders for the purchase of medicines and certain care products ‘on the basis of a multidose per resident, per day and per distribution round’, for the care homes De Zeventorentjes, De Vliedberg and Het Hallenhuis. The contract ‘Supply of medication 2011 – 2012’ was published in the Bulletin of Tenders on 11 October 2010. Specifications no. 132/201009/OZ/MG/VVV provided for a one-year call-off supply contract, including a three-month trial period, and gave the chosen supplier exclusivity for all material during that period. There were two award criteria. ‘Price discount for residents’ (30 points) assessed the discount on non-reimbursed prescription medicines, non-prescription medicines and care products, 10 points each. ‘Administrative cost CPAS’ (70 points) was a percentage of total turnover, intended as compensation for the care homes’ efforts relating to ordering, advance payments, ICT, stock management and administration; the CPAS would invoice that amount to the pharmacist monthly. The specifications added that this percentage ‘must comply with the legal requirements’. Five tenderers submitted bids: Pharma2Care NV, Bruggefarma CVBA, the temporary partnership Rusthuis Apothekers Brugge, De Lindeboom Apotheek NV and Patrona Pharma Group NV. All offered residents a discount. For the administrative cost, however, Bruggefarma entered ‘0%’, with the remark ‘not legally permitted’. It referred to the prohibition on pharmacists granting ‘any profit, discount or other benefit’ to the authorised representative or to third parties involved in dispensing. The others did make a proposal: Patrona 30%, the partnership 15%, De Lindeboom 25% and Pharma2Care 25% ‘in the form of added value’, such as medication trolleys with laptops and scanners, on-site pharmaceutical care and a software interface. The evaluation report of 20 December 2010 stated that the administrative cost ‘is not a discount, but a compensation’ for real costs, and was therefore lawful. Patrona came first with 79.75 out of 100, Bruggefarma last with 30 points. On 23 December 2010 the social welfare council awarded the contract to Patrona. By registered letter of 27 December 2010 Bruggefarma received the evaluation report, but apparently not the award decision itself, and on 8 January 2011 it applied for suspension under extreme urgency. Its single plea: any percentage above 0% was a prohibited benefit within the meaning of article 10, §§ 1 and 6, of the Medicines Act of 25 March 1964, a provision of public policy. The four other tenders were therefore substantially irregular, and its own was the only regular one. Councillor of State Pierre Barra first noted that the contract had been published after 24 February 2010, so that the Act of 23 December 2009 applied: serious harm that is difficult to repair no longer had to be shown, even below the European threshold, and only the seriousness of the plea mattered. At the hearing, when asked by the Council, Bruggefarma conceded that the care products, which were also part of the contract, do not appear to fall under the prohibition of the Medicines Act. That removed the premise of the plea: the second criterion could, prima facie, be lawfully filled in at least for the care products. The argument that this amounted to rereading the criterion did not convince, since the specifications themselves referred to ‘the legal requirements’ and Bruggefarma did not challenge the legality of that clause. That care products were allegedly only a marginal share of the package did not matter either: the subject-matter remained wider than the prohibition. As for Royal Decree no. 78 and the Royal Decree of 21 January 2009, Bruggefarma did not show that they reached further than the 1964 Act. Its criticism that Pharma2Care’s ‘added value’ was an inadmissible variant did not concern the chosen tenderer, so it had no interest in it. And the breach of the duty to state reasons was insufficiently explained. The application was dismissed, in line with the opinion of first auditor Luc Vermeire. Patrona’s intervention was dismissed too: leaving aside whether it was late (the deadline ran until 20 January 2011, the application was only sent by registered post on 1 February 2011), Patrona did not prove that its competent body had decided to take legal action. Bruggefarma bears 175 euros in costs, Patrona 125 euros for its intervention. The Council did not rule on whether the implicit decision not to award to Bruggefarma could be challenged separately.
Why does this matter?
The judgment touches on a tension that long ran through contracts for medication in care homes: may a CPAS make the pharmacist pay for the work its care homes do around that medication, while medicines law prohibits benefits to institutions in dispensing? Bruggefarma took the principled route and entered 0% on a criterion worth 70 of 100 points. That made it all or nothing: if its reading was right, all other tenders were irregular; if not, it stood no chance. The Council does not settle the medicines-law question, but lets the plea fail on a simpler point. The prohibition covers medicines, the contract also included care products, and the specifications expressly asked for an answer that complied ‘with the legal requirements’. A tenderer that considers a criterion unlawful must challenge the clause itself, rather than assume that everyone who fills it in acts irregularly. The judgment is also an early example of the new regime of the Act of 23 December 2009: from 25 February 2010, an applicant seeking suspension of an award decision under extreme urgency no longer has to show serious harm that is difficult to repair, even below the European threshold. And it is a reminder that a chosen tenderer wishing to intervene must do so on time and prove that its competent body decided to litigate.
The lesson
For bidders: if you doubt the legality of an award criterion, ask questions during the procedure or challenge the specifications themselves. Putting 0% in your tender on principle is a gamble you only win if the court fully adopts your reading of the law — and if the criterion does not also allow a lawful answer. Look at the whole subject-matter of the contract: a prohibition that covers part of the products does not make the criterion unlawful for the whole. And criticism of the tender of a bidder that did not win gets you nothing in extreme-urgency proceedings. For contracting authorities: a criterion asking bidders to pay money back to the institution is legally sensitive in the care sector. The reference to ‘the legal requirements’ in the specifications helped the CPAS here, but clear delimitation — which products, which costs, which compensation — prevents the debate from arising at all. For chosen tenderers wishing to intervene: file on time and attach your competent body’s decision.
Ask yourself
As a bidder: have you raised a criterion you consider unlawful during the procedure or challenged it directly, or are you counting on your competitors being declared irregular later? Does the prohibition you rely on cover the whole subject-matter of the contract, or only part of it? Does your criticism concern the chosen tenderer, or another one? As an authority: is it clear for which products and which costs a compensation or discount is requested, and is that consistent with sector regulation? As a chosen tenderer: do you know the deadline for intervening, and is your competent body’s decision ready?
About this database
The Council of State (Raad van State / Conseil d'État) is Belgium's supreme administrative court. In disputes over public procurement — from contract awards to tenderer exclusions — the Council of State is the final arbiter. The rulings in this database are summarised by TenderWolf in plain language, with practical lessons for tenderers and contracting authorities. View all rulings →